DERM
Journey Medical Corporation Healthcare Drug Manufacturers - Specialty & Generic
10/12
Innovation Score
Patent Activity
2/3
5 patents found
FUZZY
Cash Runway
3/3
49 months of cash remaining based on current burn rate.
Cash on hand: $27.2M
Cash on hand: $27.2M
Revenue Trajectory
2/3
Revenue: $64.7M
YoY Growth: +21.5%
YoY Growth: +21.5%
Management Quality
3/3
Insider ownership: 31.6%
SBC/Revenue: 4.5%
No reverse splits detected
SBC/Revenue: 4.5%
No reverse splits detected
Key Metrics
Market Cap
$174.3M
Revenue
$64.7M
Revenue Growth (YoY)
+21.5%
Cash on Hand
$27.2M
Cash Runway
49 months
Shares Outstanding
21.5M
Insider Ownership
31.6%
SBC / Revenue
4.5%
Sector / Industry
Healthcare / Drug Manufacturers - Specialty & Generic
Patents (5)
Match type: FUZZY — company name matched partially; verify assignee
- Iron
- Handheld steamer
- Air detoxifier
- Vacuum cleaner suction head
- Hair styling device
7-Step Risk Assessment
How DERM maps to our micro cap methodology:
- Innovation Signal 5 patents identified. This suggests the company is investing in defensible IP.
- Cash Runway Check 49 months of runway. Comfortable buffer for execution.
- Revenue Trajectory +21.5% YoY growth on $64.7M revenue. Strong growth trajectory.
- Management Alignment Insiders hold 31.6% of shares. SBC is 4.5% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $174.3M company.
Financial Detail
Free Cash Flow
$-3.3M
FCF Yield
-1.9%
Return on Equity
-36.6%
Debt / Equity
82.6%
Gross Margin
65.4%
Profit Margin
-14.8%
Operating Margin
-9.3%
Price / Book
5.40
Current Ratio
1.72
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-05-16